ACS Central Science (Mar 2024)
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
- Miroslav Kosar,
- Roman C. Sarott,
- David A. Sykes,
- Alexander E. G. Viray,
- Rosa Maria Vitale,
- Nataša Tomašević,
- Xiaoting Li,
- Rudolf L. Z. Ganzoni,
- Bilal Kicin,
- Lisa Reichert,
- Kacper J. Patej,
- Uxía Gómez-Bouzó,
- Wolfgang Guba,
- Peter J. McCormick,
- Tian Hua,
- Christian W. Gruber,
- Dmitry B. Veprintsev,
- James A. Frank,
- Uwe Grether,
- Erick M. Carreira
Affiliations
- Miroslav Kosar
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Roman C. Sarott
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- David A. Sykes
- Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, U.K.
- Alexander E. G. Viray
- Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, Oregon, United States
- Rosa Maria Vitale
- Institute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy
- Nataša Tomašević
- Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
- Xiaoting Li
- iHuman Institute, ShanghaiTech University, Shanghai, China
- Rudolf L. Z. Ganzoni
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Bilal Kicin
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Lisa Reichert
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Kacper J. Patej
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Uxía Gómez-Bouzó
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- Wolfgang Guba
- Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland
- Peter J. McCormick
- Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, U.K.
- Tian Hua
- iHuman Institute, ShanghaiTech University, Shanghai, China
- Christian W. Gruber
- Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
- Dmitry B. Veprintsev
- Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, U.K.
- James A. Frank
- Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, Oregon, United States
- Uwe Grether
- Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland
- Erick M. Carreira
- Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
- DOI
- https://doi.org/10.1021/acscentsci.3c01461
- Journal volume & issue
-
Vol. 10,
no. 5
pp. 956 – 968
Abstract
No abstracts available.